(Q40424761)

20 September 2017

1 reference

title

Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial (English)

1 reference

20 September 2017

1 reference

F. Duron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579008

20 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7579008

20 May 2024

publication date

1 January 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0753332296826436?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

https://api.elsevier.com/content/article/PII:0753332296826436?httpAccept=text/plain

20 May 2024

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Biomedicine and Pharmacotherapy

20 May 2024

published in

1 reference

20 September 2017

volume

49

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

278-282

1 reference

Implications of the Diabetes Control and Complications Trial. American Diabetes Association

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes

20 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Glycation products and the pathogenesis of diabetic complications

20 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

20 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

20 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Implementation of treatment protocols in the Diabetes Control and Complications Trial

20 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Clinical review 51: Implications of the Diabetes Control and Complications Trial

20 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes

20 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

20 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Effects of Pancreatic Transplantation on Diabetic Neuropathy

20 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Epidemiology of proliferative diabetic retinopathy

20 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

20 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

The changing natural history of nephropathy in type I diabetes

20 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

20 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

The diabetes control and complications trial. Implications for policy and practice

20 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics

20 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

The incidence of vision loss in a diabetic population

20 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus

20 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Diabetic regulation and its relationship to microangiopathy

20 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years

20 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

20 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Lessons from the Diabetes Control and Complications Trial

20 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Diabetic retinopathy and pancreas transplantation: a 3-year follow-up.

20 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients

20 May 2024

32

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Diabetic microangiopathy and the control of blood glucose

20 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats

20 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Relation of diabetic control to development of microvascular complications

20 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Why do some diabetics develop severe microvascular complications?

20 May 2024

36

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

Influence of the degree of control of diabetes on the prevention, postponement and amelioration of late complications

20 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0753-3322(96)82643-6

20 May 2024

Identifiers

1 reference

20 September 2017

1 reference